The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial
Open accessAbstract
OBJECTIVE: To determine the efficacy of a 23-valent pneumococcal polysaccharide vaccine in people at high risk of pneumococcal pneumonia. DESIGN: Prospective, randomised, placebo controlled double blind study. SETTING: Nursing homes in Japan. PARTICIPANTS: 1006 nursing home residents. INTERVENTIONS: Participants were randomly allocated to either 23-valent pneumococcal polysaccharide vaccine (n=502) or placebo (n=504). MAIN OUTCOME MEASURES: The primary end points were the incidence of all cause pneumonia and pneumococcal pneumonia. Secondary end points were deaths from pneumococcal pneumonia, all cause pneumonia, and other causes. RESULTS: Pneumonia occurred in 63 (12.5%) participants in the vaccine group and 104 (20.6%) in the placebo group. Pneumococcal pneumonia was diagnosed in 14 (2.8%) participants in the vaccine group and 37 (7.3%) in the placebo group (P<0.001). All cause pneumonia and pneumococcal pneumonia were significantly more frequent in the placebo group than in the vaccine group: incidence per 1000 person years 55 v 91 (P<0.0006) and 12 v 32 (P<0.001), respectively. Death from pneumococcal pneumonia was significantly higher in the placebo group than in the vaccine group (35.1% (13/37) v 0% (0/14), P<0.01). The death rate from all cause pneumonia (vaccine group 20.6% (13/63) v placebo group 25.0% (26/104), P=0.5) and from other causes (vaccine group 17.7% (89/502) v placebo group (80/504) 15.9%, P=0.4) did not differ between the two study groups. CONCLUSION: The 23-valent pneumococcal polysaccharide vaccine prevented pneumococcal pneumonia and reduced mortality from pneumococcal pneumonia in nursing home residents. Trial registration Japan Medical Association Center for Clinical Trials JMA-IIA00024.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
(1997) · PsycEXTRA Dataset · doi:10.1037/e547512006-001 · Cited by 1,000
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
Jackson, L. A., Neuzil, K. M., Yu, O., Benson, P., Barlow, W. E., Adams, A. L., Hanson, C. A., Mahoney, L. D., Shay, D. K., & Thompson, W. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022678 · Cited by 608
French, N., Nakiyingi, J., Carpenter, L., Lugada, E., Watera, C., Moi, K., Moore, M., Antvelink, D., Mulder, D., Janoff, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02377-1 · Cited by 461
Janssens, J.-P., & Krause, K.-H. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00931-4 · Cited by 440
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub2 · Cited by 387
Örtqvist, Å., Hedlund, J., Burman, L.-Å., Elbel, E., Höfer, M., Leinonen, M., Lindblad, I., Sundelöf, B., & Kalin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07358-3 · Cited by 376
The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
SIMS, R. V., STEINMANN, W. C., MCCONVILLE, J. H., KING, L. R., ZWICK, W. C., & SCHWARTZ, J. S. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-653 · Cited by 317
Muder, R. R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00262-9 · Cited by 296
Nuorti, J. P., Butler, J. C., Crutcher, J. M., Guevara, R., Welch, D., Holder, P., & Elliott, J. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382601 · Cited by 270
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Marcos, M. A., Jiménez de Anta, M. T., de la Bellacasa, J. P., González, J., Martínez, E., García, E., Mensa, J., de Roux, A., & Torres, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00058802 · Cited by 188
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Christenson, B., Hedlund, J., Lundbergh, P., & Örtqvist, Å. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00063504 · Cited by 162
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Lim, W. S., & Macfarlane, J. T. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00204401 · Cited by 157
Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia
Johnstone, J., Marrie, T. J., Eurich, D. T., & Majumdar, S. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.18.1938 · Cited by 143
Kaufman, P. (1947) · Archives of Internal Medicine · doi:10.1001/archinte.1947.00220110058004 · Cited by 123
[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
GAILLAT, J., Zmirou‐Navier, D., Mallaret, M., Rouhan, D., Bru, J. P., Stahl, J. ‐., Delormas, P., & Micoud, M. (1985) · PubMed · Cited by 115
Domínguez, A., Salleras, L., Fedson, D. S., Izquierdo, C., Ruíz, L., Ciruela, P., Fenoll, A., & Casal, J. (2005) · Clinical Infectious Diseases · doi:10.1086/429236 · Cited by 95
Maruyama, T., Niederman, M. S., Kobayashi, T., Kobayashi, H., Takagi, T., D'Alessandro-Gabazza, C. N., Fujimoto, H., Gil Bernabe, P., Hirohata, S., Nakayama, S., et al. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.03.027 · Cited by 82
Self-citationMusher, D. M., Mediwala, R., Phan, H. M., Chen, G. L., & BAUGHN, R. E. (2001) · Clinical Infectious Diseases · doi:10.1086/318709 · Cited by 43
Howell, T. H. (1945) · Postgraduate Medical Journal · doi:10.1136/pgmj.21.230.20 · Cited by 41
Roux, A. D., & Lode, H. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00119705 · Cited by 7
Cited by
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Torres, A., Cilloniz, C., Niederman, M. S., Menéndez, R., Chalmers, J. D., Wunderink, R. G., & van der Poll, T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00259-0 · Cited by 798
Self-citationGuidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Effect of exercise therapy on cytokine secretion in the saliva of bedridden patients.
Iki, H., Sawa, S., Teranishi, T., Tomita, M., Nishii, K., & Yamada, K. (2016) · Journal of Physical Therapy Science · doi:10.1589/jpts.28.2871 · Cited by 5
Metadata
- Authors
- Maruyama, T., Taguchi, O., Niederman, M. S., Morser, J., Kobayashi, H., Kobayashi, T., D'Alessandro-Gabazza, C., Nakayama, S., Nishikubo, K., Noguchi, T., Takei, Y., & Gabazza, E. C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-03-08
- Volume
- 340
- Issue
- mar08 1
- Pages
- c1004-c1004
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2054121591
- Cited by
- 279
- References
- 23
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.